Skip to main content
Fig. 2 | Chinese Medicine

Fig. 2

From: Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro

Fig. 2

Effects of LS (2, 1 and 0.5 μg/mL) or Remdesivir on the mRNA expression levels of inflammatory mediators (IL-6, IL-8, IP-10, CCL-5 and MIP-1α) in the 501Y.V2/B.1.351 strain-infected cells. Data were presented as the mean ± SD obtained from three separate experiments. *P < 0.05; **P < 0.01; ***P < 0.001, compared with the 501Y.V2/B.1.351 strain-infected cells

Back to article page

Chinese Medicine

ISSN: 1749-8546

Contact us